Titan Quick Ratio from 2010 to 2024

TTNP Stock  USD 7.32  0.22  3.10%   
Titan Pharmaceuticals Quick Ratio yearly trend continues to be relatively stable with very little volatility. Quick Ratio is likely to grow to 7.92 this year. Quick Ratio is a measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities. View All Fundamentals
 
Quick Ratio  
First Reported
2010-12-31
Previous Quarter
5.41481994
Current Value
7.92
Quarterly Volatility
1.94664766
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Titan Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Titan main balance sheet or income statement drivers, such as Depreciation And Amortization of 106.4 K, Interest Expense of 31.7 K or Total Revenue of 174.8 K, as well as many exotic indicators such as Price To Sales Ratio of 32.03, Dividend Yield of 0.0015 or PTB Ratio of 0.89. Titan financial statements analysis is a perfect complement when working with Titan Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Titan Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Titan Pharmaceuticals Technical models . Check out the analysis of Titan Pharmaceuticals Correlation against competitors.
To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.

Latest Titan Pharmaceuticals' Quick Ratio Growth Pattern

Below is the plot of the Quick Ratio of Titan Pharmaceuticals over the last few years. It is a measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities. Titan Pharmaceuticals' Quick Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Titan Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Quick Ratio10 Years Trend
Slightly volatile
   Quick Ratio   
       Timeline  

Titan Quick Ratio Regression Statistics

Arithmetic Mean2.56
Geometric Mean1.91
Coefficient Of Variation75.94
Mean Deviation1.37
Median1.78
Standard Deviation1.95
Sample Variance3.79
Range7.7849
R-Value0.60
Mean Square Error2.60
R-Squared0.36
Significance0.02
Slope0.26
Total Sum of Squares53.05

Titan Quick Ratio History

2024 7.92
2023 5.41
2022 1.13
2021 2.3
2020 1.49
2019 1.73
2018 3.22

About Titan Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Titan Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Titan Pharmaceuticals investors use historical funamental indicators, such as Titan Pharmaceuticals's Quick Ratio, to determine how well the company is positioned to perform in the future. Although Titan Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Titan Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Titan Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Titan Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Titan Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Quick Ratio 5.41  7.92 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Titan Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Titan Pharmaceuticals' short interest history, or implied volatility extrapolated from Titan Pharmaceuticals options trading.

Currently Active Assets on Macroaxis

When determining whether Titan Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Titan Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Titan Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Titan Pharmaceuticals Stock:
Check out the analysis of Titan Pharmaceuticals Correlation against competitors.
To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Titan Stock analysis

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Titan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Titan Pharmaceuticals. If investors know Titan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Titan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.41)
Revenue Per Share
0.245
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.75)
Return On Equity
(1.39)
The market value of Titan Pharmaceuticals is measured differently than its book value, which is the value of Titan that is recorded on the company's balance sheet. Investors also form their own opinion of Titan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Titan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Titan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Titan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Titan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Titan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Titan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.